[1] [3] Regarding potential protective effects, some preclinical research suggests GLP-1 receptors are expressed in retinal tissue, and GLP-1 agonists may have neuroprotective and anti-inflammatory properties in laboratory studies
The ability to reduce cardiovascular (CV) risk in patients with type 2 diabetes is another factor that could drive greater GLP-1 utilization
Understanding these differences can help researchers select the most appropriate compound for their investigative goals
Seek assistance from healthcare providers if symptoms persist
67 Non-proliferative astrogliosis typically occurs in neural tissue that is responding to a pathology but is not overtly damaged and retains its basic tissue architecture, for example (i) during diffuse neuroinflammation caused by peripheral exposure to microbial antigens such as lipopolysaccharide (LPS), 68,69 (ii) in tissue regions that are at a distance from focal lesions (diaschisis) caused by stroke, trauma or autoimmune attack, 8,70 or (iii) in tissue undergoing neurodegenerative changes